Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Willard › NPI 1790731016
Hospital

Mercy Health - Willard Hospital LLC

Mercy Health - Willard Hospital LLC was paid $4.88M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.

33Billing provider infoMERCY HEALTH - WILLARD HOSPITAL LLC
WILLARD, OH 44890
33aNPI1790731016assigned 05/26/2006
33bProvider typeCritical Access Hospital
28Total paid$4.88M
24GClaims114,591
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Ohio

Rank by total paid#15 of 26
Median peer was paid$5.33M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201811,327$411K
201910,544$378K
20209,510$477K
202113,158$679K
202212,339$662K
202335,740$1.35M
2024incomplete21,973$922K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 45% 16,896 15,574 $2.17M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 19% 6,879 5,981 $915K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.2% 2,393 1,949 $351K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.5% 2,722 2,548 $316K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.8% 2,282 599 $139K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.5% 591 586 $124K
70450 Computed tomography, head or brain; without contrast material 1.6% 283 223 $76K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 423 271 $71K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.5% 2,009 1,906 $71K
80053 Comprehensive metabolic panel 1.4% 7,960 6,872 $70K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.3% 263 163 $64K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.3% 840 285 $62K
80 more codes
96361 Intravenous infusion, hydration; each additional hour <1% 143 $47K
84443 Thyroid stimulating hormone (TSH) <1% 1,791 $36K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 109 $29K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,288 $29K
80061 Lipid panel <1% 1,483 $28K
80048 Basic metabolic panel (calcium, ionized) <1% 3,043 $26K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 11,200 $24K
71046 Radiologic examination, chest; 2 views <1% 1,289 $21K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 541 $19K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 860 $18K
36415 Collection of venous blood by venipuncture <1% 10,388 $18K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,259 $15K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 241 $13K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 66 $13K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 759 $9K
83036 Hemoglobin; glycosylated (A1C) <1% 498 $8K
83735 <1% 1,072 $8K
84484 <1% 2,109 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 354 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,253 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 16 $5K
84439 <1% 151 $4K
73110 <1% 79 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 315 $4K
71045 Radiologic examination, chest; single view <1% 1,857 $4K
80076 <1% 353 $4K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 25 $3K
80320 <1% 342 $3K
97162 <1% 83 $3K
73610 <1% 71 $3K
73564 <1% 65 $3K
85027 <1% 466 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,589 $2K
77067 Screening mammography, bilateral, including computer-aided detection <1% 47 $2K
73630 <1% 121 $2K
74018 <1% 61 $2K
83605 <1% 527 $2K
81001 <1% 3,340 $2K
73130 <1% 35 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,255 $1K
83690 <1% 1,306 $1K
85610 <1% 828 $1K
87186 <1% 231 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,117 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 1,662 $781.44
92523 <1% 12 $777.98
82947 <1% 525 $754.35
84703 <1% 824 $672.64
86140 <1% 30 $666.06
85379 <1% 344 $569.91
72110 <1% 15 $543.20
81003 <1% 579 $428.62
85652 <1% 64 $409.46
83540 <1% 33 $401.01
94664 <1% 157 $314.14
82607 <1% 12 $304.93
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 13 $238.61
83550 <1% 15 $211.07
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 13 $194.16
81025 <1% 392 $108.31
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 288 $76.05
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 53 $70.66
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,643 $50.80
83880 <1% 16 $45.51
87807 <1% 47 $37.59
80143 <1% 18 $36.28
80179 <1% 15 $18.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 592 $14.84
87077 <1% 16 $14.52
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,253 $9.68
J2704 Injection, propofol, 10 mg <1% 369 $9.55
87040 <1% 25 $6.57
J3010 Injection, fentanyl citrate, 0.1 mg <1% 170 $5.96
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 26 $1.85
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 55 $0.63
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 626 $0.00
80306 0% 12 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 35 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 47 $0.00
85730 0% 28 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDETTERMAN, BUFFY (CEO)